{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:14:48Z","timestamp":1790432088884,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00262-013-1453-3","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T11:25:15Z","timestamp":1372677915000},"page":"1499-1509","source":"Crossref","is-referenced-by-count":280,"title":["Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma"],"prefix":"10.1007","volume":"62","author":[{"given":"Einar Osland","family":"Vik-Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Nyakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birthe Viftrup","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Carstens","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Due-T\u00f8nnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else Marit Inderberg","family":"Suso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"S\u00e6b\u00f8e-Larssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.","family":"Brinchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik","family":"Helseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Lote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinar","family":"Aamdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Gaudernack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Kvalheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver A.","family":"Langmoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,2]]},"reference":[{"key":"1453_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC\u2013NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"1453_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105\u2013111","journal-title":"Nature"},{"key":"1453_CR3","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","volume":"13","author":"L Vermeulen","year":"2012","unstructured":"Vermeulen L, de Sousa e Melo F, Richel DJ, Medema JP (2012) The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol 13:e83\u2013e89","journal-title":"Lancet Oncol"},{"key":"1453_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/glia.10094","volume":"39","author":"TN Ignatova","year":"2002","unstructured":"Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193\u2013206","journal-title":"Glia"},{"key":"1453_CR5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1553558","volume":"255","author":"BA Reynolds","year":"1992","unstructured":"Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707\u20131710","journal-title":"Science"},{"key":"1453_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ccr.2009.12.049","volume":"17","author":"R Chen","year":"2010","unstructured":"Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM et al (2010) A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17:362\u2013375","journal-title":"Cancer Cell"},{"key":"1453_CR7","doi-asserted-by":"crossref","first-page":"e15844","DOI":"10.1371\/journal.pone.0015844","volume":"6","author":"LP Deleyrolle","year":"2011","unstructured":"Deleyrolle LP, Ericksson G, Morrison BJ, Lopez JA, Burrage K, Burrage P et al (2011) Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PLoS ONE 6:e15844","journal-title":"PLoS ONE"},{"key":"1453_CR8","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/brain\/awh574","volume":"128","author":"MC Moe","year":"2005","unstructured":"Moe MC, Varghese M, Danilov AI, Westerlund U, Ramm-Pettersen J, Brundin L et al (2005) Multipotent progenitor cells from the adult human brain: neurophysiological differentiation to mature neurons. Brain 128:2189\u20132199","journal-title":"Brain"},{"key":"1453_CR9","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-04-1364","volume":"64","author":"R Galli","year":"2004","unstructured":"Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011\u20137021","journal-title":"Cancer Res"},{"key":"1453_CR10","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821\u20135828","journal-title":"Cancer Res"},{"key":"1453_CR11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1227\/01.NEU.0000335792.85142.B0","volume":"63","author":"M Varghese","year":"2008","unstructured":"Varghese M, Olstorn H, Sandberg C, Vik-Mo EO, Noordhuis P, Nist\u00e9r M et al (2008) A comparison between stem cells from the adult human brain and from brain tumors. Neurosurgery 63:1022\u20131033","journal-title":"Neurosurgery"},{"key":"1453_CR12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756\u2013760","journal-title":"Nature"},{"key":"1453_CR13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/glia.20414","volume":"54","author":"A Salmaggi","year":"2006","unstructured":"Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C, Ciusani E et al (2006) Glioblastoma-derived tumorspheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54:850\u2013860","journal-title":"Glia"},{"key":"1453_CR14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","volume":"456","author":"E Quintana","year":"2008","unstructured":"Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008) Efficient tumour formation by single human melanoma cells. Nature 456:593\u2013598","journal-title":"Nature"},{"key":"1453_CR15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P et al (2011) Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17:1086\u20131093","journal-title":"Nat Med"},{"key":"1453_CR16","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1001\/jama.2010.1862","volume":"304","author":"AJ Gentles","year":"2010","unstructured":"Gentles AJ, Plevritis SK, Majeti R, Alizadeh AA (2010) Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 304:2706\u20132715","journal-title":"JAMA"},{"key":"1453_CR17","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1634\/stemcells.2006-0114","volume":"24","author":"MB Herrera","year":"2006","unstructured":"Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Dereqibus MC et al (2006) Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24:2840\u20132850","journal-title":"Stem Cells"},{"key":"1453_CR18","doi-asserted-by":"crossref","first-page":"e25265","DOI":"10.1371\/journal.pone.0025265","volume":"6","author":"M Takamiya","year":"2011","unstructured":"Takamiya M, Haider KH, Ashraf M (2011) Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration. PLoS ONE 6:e25265","journal-title":"PLoS ONE"},{"key":"1453_CR19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1089\/scd.2008.0338","volume":"18","author":"Y Wu","year":"2009","unstructured":"Wu Y, Wu PY (2009) CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 18:1127\u20131134","journal-title":"Stem Cells Dev"},{"key":"1453_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.cgt.7700961","volume":"13","author":"JA Kyte","year":"2006","unstructured":"Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M et al (2006) Phase I\/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Ther 13:905\u2013918","journal-title":"Cancer Gene Ther"},{"key":"1453_CR21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjc.6602761","volume":"93","author":"LJ Mu","year":"2005","unstructured":"Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M et al (2005) Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer 93:749\u2013756","journal-title":"Br J Cancer"},{"key":"1453_CR22","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1158\/0008-5472.CAN-09-2687","volume":"69","author":"CE Brown","year":"2009","unstructured":"Brown CE, Starr R, Martinez C, Aquilar B, D\u2019Apuzzo M, Todorov I et al (2009) Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells. Cancer Res 69:8886\u20138893","journal-title":"Cancer Res"},{"key":"1453_CR23","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.1158\/0008-5472.CAN-06-2048","volume":"66","author":"S Pellegatta","year":"2006","unstructured":"Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B et al (2006) Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66:10247\u201310252","journal-title":"Cancer Res"},{"key":"1453_CR24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-1759(01)00506-3","volume":"259","author":"S Saeboe-Larssen","year":"2002","unstructured":"Saeboe-Larssen S, Fossberg E, Gaudernack G (2002) mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods 259:191\u2013203","journal-title":"J Immunol Methods"},{"key":"1453_CR25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00262-011-0991-9","volume":"60","author":"EM Suso","year":"2011","unstructured":"Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G et al (2011) hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes. Cancer Immunol Immunother 60:809\u2013818","journal-title":"Cancer Immunol Immunother"},{"key":"1453_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0404.2010.01350.x","volume":"122","author":"R Helseth","year":"2010","unstructured":"Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, R\u00f8nning P et al (2010) Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122:159\u2013167","journal-title":"Acta Neurol Scand"},{"key":"1453_CR27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/neuonc\/noq102","volume":"12","author":"EO Vik-Mo","year":"2010","unstructured":"Vik-Mo EO, Sandberg C, Olstorn H, Varghese M, Brandal P, Ramm-Pettersen J et al (2010) Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions. Neuro Oncol 12:1220\u20131230","journal-title":"Neuro Oncol"},{"key":"1453_CR28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.yexcr.2010.12.022","volume":"317","author":"EO Vik-Mo","year":"2011","unstructured":"Vik-Mo EO, Sandberg C, Joel M, Stangeland B, Watanabe Y, Mackay-Sim A et al (2011) A comparative study of the structural organization of spheres derived from the adult human subventricular zone and glioblastoma biopsies. Exp Cell Res 317:1049\u20131059","journal-title":"Exp Cell Res"},{"key":"1453_CR29","first-page":"1028","volume":"60","author":"D Boczkowski","year":"2000","unstructured":"Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E (2000) Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 60:1028\u20131034","journal-title":"Cancer Res"},{"key":"1453_CR30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.cgt.7700837","volume":"12","author":"JA Kyte","year":"2005","unstructured":"Kyte JA, Kvalheim G, Aamdal S, Saeboe-Larssen S, Gaudernack G (2005) Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination. Cancer Gene Ther 12:579\u2013591","journal-title":"Cancer Gene Ther"},{"key":"1453_CR31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent R, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"1453_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/neuonc\/nor195","volume":"14","author":"H Wakimoto","year":"2012","unstructured":"Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, Nitta M et al (2012) Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol 14:132\u2013144","journal-title":"Neuro Oncol"},{"key":"1453_CR33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/stem.264","volume":"28","author":"AC deCarvalho","year":"2010","unstructured":"deCarvalho AC, Nelson K, Lemke N, Lehman NL, Arbab AS, Kalkanis S et al (2010) Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells 28:181\u2013190","journal-title":"Stem Cells"},{"key":"1453_CR34","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1038\/sj.onc.1207946","volume":"23","author":"SK Singh","year":"2004","unstructured":"Singh SK, Clarke ID, Hide T, Dirks PB (2004) Cancer stem cells in nervous system tumors. Oncogene 23:7267\u20137273","journal-title":"Oncogene"},{"key":"1453_CR35","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/stem.15","volume":"27","author":"DR Laks","year":"2009","unstructured":"Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I et al (2009) Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cell 27:980\u2013987","journal-title":"Stem Cell"},{"key":"1453_CR36","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1158\/1078-0432.CCR-08-0644","volume":"14","author":"R Pallini","year":"2008","unstructured":"Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M et al (2008) Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14:8205\u20138212","journal-title":"Clin Cancer Res"},{"key":"1453_CR37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-006-9265-3","volume":"83","author":"A Wu","year":"2007","unstructured":"Wu A, Wiesner S, Xiao J, Ericson K, Chen W, Hall WA et al (2007) Expression of MHC I and NK ligands on human CD 133+ glioma cells: possible targets of immunotherapy. J Neurooncol 83:121\u2013131","journal-title":"J Neurooncol"},{"key":"1453_CR38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Research Genome Atlas Network","year":"2008","unstructured":"Cancer Research Genome Atlas Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061\u20131068","journal-title":"Nature"},{"key":"1453_CR39","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1158\/0008-5472.CAN-09-1707","volume":"70","author":"C Lottaz","year":"2010","unstructured":"Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J et al (2010) Transcriptional profiles of CD133+ and CD133\u2212 glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res 70:2030\u20132040","journal-title":"Cancer Res"},{"key":"1453_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/14737140.9.1.67","volume":"9","author":"RS Johnson","year":"2009","unstructured":"Johnson RS, Walker AI, Ward SJ (2009) Cancer vaccines: will we ever learn? Expert Rev Anticancer Ther 9:67\u201374","journal-title":"Expert Rev Anticancer Ther"},{"key":"1453_CR41","doi-asserted-by":"crossref","first-page":"e23288","DOI":"10.4161\/onci.23288","volume":"2","author":"TZ Iversen","year":"2013","unstructured":"Iversen TZ, Brimnes MK, Nikolaisen K, Andersen RS, Hadrup SR, Andersen MH et al (2013) Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients. Oncoimmunology 2:e23288","journal-title":"Oncoimmunology"},{"key":"1453_CR42","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1158\/1078-0432.CCR-11-0184","volume":"17","author":"JA Kyte","year":"2011","unstructured":"Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011) Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients. Clin Cancer Res 17:4568\u20134580","journal-title":"Clin Cancer Res"},{"key":"1453_CR43","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00262-012-1261-1","volume":"61","author":"H Ardon","year":"2012","unstructured":"Ardon H, Van Gool S, Verschuere T, Maes W, Fieuws S, Sciot R et al (2012) Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I\/II trial. Cancer Immunol Immunother 61:2033\u20132044","journal-title":"Cancer Immunol Immunother"},{"key":"1453_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri1355","volume":"4","author":"Z Grossman","year":"2004","unstructured":"Grossman Z, Min B, Meier-Schellersheim M, Paul WE (2004) Concomitant regulation of T-cell activation and homeostasis. Nat Rev Immunol 4:387\u2013395","journal-title":"Nat Rev Immunol"},{"key":"1453_CR45","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1227\/01.NEU.0000141082.20865.48","volume":"55","author":"P Parajuli","year":"2004","unstructured":"Parajuli P, Mathupala S, Sloan AE (2004) Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells. Neurosurgery 55:1194\u20131204","journal-title":"Neurosurgery"},{"key":"1453_CR46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exer.2008.09.020","volume":"88","author":"MC Moe","year":"2009","unstructured":"Moe MC, Kolberg RS, Sandberg C, Vik-Mo E, Olstorn H, Varghese M et al (2009) A comparison of epithelial and neural properties in progenitor cells derived from the adult human ciliary body and brain. Exp Eye Res 88:30\u201338","journal-title":"Exp Eye Res"},{"key":"1453_CR47","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/stem.102","volume":"27","author":"Q Xu","year":"2009","unstructured":"Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J et al (2009) Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27:1734\u20131740","journal-title":"Stem Cells"},{"key":"1453_CR48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00262-012-1319-0","volume":"62","author":"S Puphanich","year":"2013","unstructured":"Puphanich S, Wheeler CJ, Rudnick J, Mazer M, Wang HQ, Nuno M et al (2013) Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol Immunother 62:125\u2013135","journal-title":"Cancer Immunol Immunother"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-013-1453-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1453-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T22:15:36Z","timestamp":1645913736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-013-1453-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,2]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1007\/s00262-013-1453-3","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,2]]}}}